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Thrombocytopenia THC4Inherited thrombocytopenias are heterogeneous diseases caused by at least 20 genes playing different role in the
processes of megakaryopoiesis and platelet production. Some forms, such as thrombocytopenia 4 (THC4), are
very rare and not well characterized. THC4 is an autosomal dominant mild thrombocytopenia described in
only one large family from New Zealand and due to a mutation (G41S) of the somatic isoform of the cytochrome
c (CYCS) gene. We report a novel CYCSmutation (Y48H) in patients from an Italian family. Similar to individuals
carrying G41S, they have platelets of normal size and morphology, which are only partially reduced in number,
but no prolonged bleeding episodes. In order to determine the pathogenetic consequences of Y48H, we studied
the effects of the two CYCSmutations in yeast and mouse cellular models. In both cases, we found reduction of
respiratory level and increased apoptotic rate, supporting the pathogenetic role of CYCS in thrombocytopenia.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Inherited thrombocytopenias are a heterogeneous group of diseases
due to mutations in at least 20 different genes [1]. Some of these forms
are very rare being diagnosed only in a few patients worldwide. This is
the case of thrombocytopenia 4 (THC4; OMIM 612004), an autosomal
dominant form described in a single family from New Zealand [2]. In
this family, the thrombocytopenia is caused by the G41S mutation of
the somatic isoform of the cytochrome c (CYCS) gene, the only naturally
occurring mutation identiﬁed in this gene.
Cytochrome c is an evolutionarily well-conserved small protein of
the inner membrane of the mitochondrion. It contains a heme group
that shuttles electrons from complex III to complex IV of the mitochon-
drial electron-transport chain. Moreover, cytochrome c is also involved
in initiation of the intrinsic pathway of apoptosis. Upon its release to the
cytoplasm, it leads to apoptosome formation,which in turn activates the
caspase cascade [3].ciences, University of Trieste,
, Italy. Tel.: +39 040 3785527;
).
ights reserved.Despite the ubiquitous expression of cytochrome c, the THC4 pa-
tients presented only with deregulated megakaryopoiesis, with ineffec-
tive platelet production due to ectopic platelet release within bone
marrow [2]. Oxygen consumption was normal, suggesting that G41S
does not affect electron transfer. It is instead stimulated apoptosome
formation and caspase activation.However, it has recently been demon-
strated that G41S alters the heme electronic structure of cytochrome c
and increases its electron self-exchange rate, suggesting that the heme
changes might be responsible for the proapoptotic effect of the muta-
tion [4].
Although no CYCSmutation was previously revealed in 77 unrelated
patients selected froma large series of individualswith inherited throm-
bocytopenias [5], routine screening led us to identify a secondmissense
mutation of CYCS, whose pathogenetic role was investigated in mouse
and yeast models.2. Materials and methods
2.1. Patients
The proband (III-3; Fig. 1A) was a 3-year-old boy, who was referred
to theDivision of PediatricHematology/Oncology (University of Catania)
because of thrombocytopenia revealed on a routine check-up. His
A B
C
Fig. 1. Identiﬁcation of theY48Hmutation. (A) Proband's (III-3) family pedigree showing platelet number (PLT, reported in ×109/L), mean platelet volume (MPV, reported in fL) and seg-
regation of the p.Y48Hmutation. To conform to mutation nomenclature of literature, in this paper we refer to the amino acid after the ﬁrst methionine of cytochrome c (NP_061820.1) as
residue +1. (B) Direct sequencing of PCR product with the overlapping peaks of the heterozygous c.145TNC mutation. (C) Alignment of cytochrome c in different species, showing con-
servation of tyrosine 48. Hs, Homo sapiens (NP_061820.1); Mm, Mus musculus (NP_031834.1); Gg, Gallus gallus (NP_001072946.1); Dr, Danio rerio (NP_001002068.1); Dm, Drosophila
melanogaster (NP_477176.1); At, Arabidopsis thaliana (NP_173697.1); Sc, Saccharomyces cerevisiae (NP_012582.1); Bm; Brucella melitensis (NP_542046.1). Amino acids conserved during
evolution are in bold.
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6.8 ﬂ (normal value 6.5–11). He had no personal or familial history of
bleeding though his father also had thrombocytopenia. The investiga-
tion was extended to all family members, who gave written informed
consent to the investigation according to the Declaration of Helsinki.
All the other forms of inherited thrombocytopenia were excluded ac-
cording to the diagnostic algorithm proposed by the Italian Platelet
Study Group and subsequently updated [6,7].
2.2. Mutational screening of CYCS
The CYCS gene was screened for mutations using genomic DNA
extracted from peripheral blood. Mutation analysis was performed
by polymerase chain reaction (PCR) using oligonucleotides 5′-AGTGGC
TAGAGTGGTCATTC-3′ and 5′-TTAACCACAAGCCAGTCTTAG-3′. PCR was
carried out in a total volume of 25 μL with 80 ng of genomic DNA, 1 μL
of each primer 10 μM, 2 μL of MgCl2 25 mM, 2 μL of dNTPs 2.5 mM,
1.5 U of AmpliTaq Gold DNA polymerase (Applied Biosystems, USA)
and 2.5 μL of the corresponding 10× PCRbuffer. After an initial denatur-
ation step at 95 °C for 12 min, ampliﬁcationwas performed for 30 cycles
(denaturation at 95 °C for 40 s, annealing at 60 °C for 45 s and exten-
sion at 72 °C for 1 min). PCR products were sequenced using the ABI
PRISM BigDye Terminator Cycle Sequencing Read Reaction kit and ABI
1310 Genetic Analyzer (Applied Biosystems, USA).
2.3. Cloning of yeast and murine cDNA
The yeast cytochrome c gene (CYC1; NM_001181706.1) and its 5′
and 3′ ﬂanking regions were ampliﬁed using genomic DNA of strain
BY4741 as template and primers 5′-CCCCAAGCTTCGTGTGAGACGACA
TCGTCG-3′ and 5′-CCCCGGATCCGGACCTAGACTTCAGGTTGTC-3′. The
PCR product was cloned into the pFL38 centromeric plasmid [8]. TheCYC1Y53H and CYC1G46S mutant alleles, which correspond to the human
CYCSY48H and CYCSG41S alleles, respectively, were produced by site-
directedmutagenesis usingQuikChange II Site-DirectedMutagenesis Kit
(Stratagene, La Jolla, CA) usingmodiﬁed primers 5′-GGTCAAGCTGAAGG
GTATTCGCACACAGATGCCAATATCAAGAA and 5′-TTCTTGATATTGGCAT
CTGTGTGCGAATACCCTTCAGCTTGACC-3′ for CYC1Y53H or 5′-GGTATCTT
TGGCAGACACTCTAGTCAAGCTGAAGGGTATTCG-3′ and 5′-CGAATACC
CTTCAGCTTGACTAGAGTGTCTGCCAAAGATACC-3′ for CYC1G46S (base
changes are in bold). Both wild-type and mutagenized inserts were
sequence-veriﬁed on both strands.
The murine cytochrome c (Cycs; NM_007808.4) coding region was
ampliﬁed from cDNA using primers 5′-GGGACGTCTGTCTTCGAGTC-3′
and 5′-AAGCCATGAGACATTTGTTTTG-3′ with Platinum PCR SuperMix
(Invitrogen, USA) and cloned into pCR8/GW/TOPO-TA (Invitrogen,
USA). The G41S and Y48H mutations were introduced using the
QuikChange II Site DirectedMutagenesis kit (Stratagene, La Jolla, CA) ac-
cording tomanufacturer's protocolwith primers 5′-TGTTCGGGCGGAAG
ACAAGCCAGGCTG-3′ and 5′-CAGCCTGGCTTGTCTTCCGCCCGAACA-3′
for CycsG41S, and 5′-GGCCAGGCTGCTGGATTCTCTCACACAGATGCC-3′
and 5′-GGCATCTGTGTGAGAGAATCCAGCAGCCTGGCC-3′ for CycsY48H
(base changes are in bold). Plasmids were sequenced using the
BigDyeCycle Reaction System v3.1 kit (Applied Biosystems, USA) and
the ABI PRISM 3100 automated sequencer (Applied Biosystems, USA).
The sequences of the wild-type and mutant Cycs were subcloned into
the retroviral transducing vector pMSCV via homologous recombina-
tion, using the Gateway LR Clonase II Enzyme Mix Kit (Invitrogen,
USA), according to manufacturer's protocol.
2.4. Yeast and murine cell culture, transformation and transduction
Saccharomyces cerevisiae strain BY4741 (MATa; his3Δ1 leu2Δ0
met15Δ0 ura3Δ0) and its isogenic strain CYC1::kanMX4 (Δcyc1) were
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without amino acids (ForMedium™, United Kingdom)] supplemented
with 1 g/L of drop-out powder containing all amino acids and bases ex-
cept those required for plasmidmaintenance [9]. Various carbon sources
were added at 2% (w/v) (Carlo Erba Reagents, Italy). Media were solidi-
ﬁed with 20 g/L agar (ForMedium™, United Kingdom). For respiration
and cytochrome absorption spectra cells were grown to late-log phase
in the YNB medium supplemented with 0.6% glucose. Transformation
of yeast strain was obtained by the lithium acetate method [10].
Restriction-enzyme digestions, Escherichia coli transformation and plas-
mid extractions were performed using standard methods [11].
Mouse lung ﬁbroblasts, where both somatic and testis cytochrome c
isoformswere deleted (Cycs−/−/Cyct−/−MLF) andmouse embryonic ﬁ-
broblasts (MEF), were cultured as previously described [12]. Retroviral
vectors were generated by co-transfecting the HEK293T cell line with
pMSCV containing the wild-type or mutant Cycs sequences and with
the helper pIK plasmid. The supernatants collected after 24 h or 48 h
were used to transduce Cycs−/−/Cyct−/−MLFs, which were then grown
in medium supplemented with hygromycin (200 μg/mL), or wild-type
MEFs.2.5. Respiration measurements and cytochrome spectra
In yeast, oxygen uptake was measured at 30 °C using a Clark-type
oxygen electrode in a 1 ml stirred chamber containing 1 ml of air-
saturated respiration buffer (0.1 M phthalate–KOH, pH 5.0) and
10 mM glucose (Oxygraph System, Hansatech Instruments, England).
The reaction was initiated with the addition of 20 mg of wet weight of
cells, as previously described [13]. Differential spectra between reduced
and oxidized cells of a suspension of cells at 60 mg/ml (wet weight)
were recorded at room temperature, using a Cary 300 Scan spectropho-
tometer (Varian, Palo Alto, CA, USA).
Murine cells were grown under standard conditions. The culture
medium was changed on the day before the measurements. Cells
were collected by trypsinization and centrifugation, and resuspended
at 7.5 × 106 cells per ml in standard medium (0.3 M mannitol, 10 mM
KCl, 5 mM MgCl2, 1 mg/ml BSA, 10 mM KH2PO4, pH 7.4). Samples
(0.3 ml)were transferred into amicrowater-jacketed cell, magnetically
stirred at 37 °C, and oxygen utilization was measured with a Clark oxy-
gen electrode (Hansatech Instruments, UK). The reaction was inhibited
with KCN (700 μM).2.6. Cell lysates and immunoblotting
Whole-cell lysates of murine cells (106) were prepared in CHAPSO
buffer (1% CHAPSO, 100 mM KCl, 50 mM HEPES pH 7.5, 1 mM EGTA)
supplemented with complete protease-inhibitor mixture (Sigma-Al-
drich, USA). Twenty micrograms of total cell lysate was separated by
SDS-PAGE using the NuPAGE 4%–12% Bis Tris Gel (Invitrogen, USA),
blotted on a polyvinyl diﬂuoridemembrane, probedwith a 1:10,000 an-
tibody against cytochrome c (BD Pharmingen, USA) and a 1:10,000 sec-
ondary HRP-conjugated antimouse antibody (Santa Cruz, USA), and
analyzed by enhanced chemiluminescence (Amersham Pharmacia Bio-
sciences, UK). As loading control, the membrane was probed with
mouse anti-actin antibody (Sigma-Aldrich, USA).2.7. Cell death
Cell death of murine cells was analyzed as previously reported [14].
Brieﬂy, 3.5 × 104 transduced cells were treatedwith 2 μMstaurosporine
(STS) for 5 h. Cellswere stainedwith propidium iodide (PI) and annexin-
V-FITC (Prodotti Gianni, Italy) and cell death was measured by ﬂow
cytometry as the percentage annexin-V-positive/PI-negative cells.3. Results
3.1. Identiﬁcation of the Y48Y mutation
Mutational screening of the CYCS gene revealed a heterozygous
substitution (c.145TNC; p.Y48H or CYCSY48H, LOVD database: http://
databases.lovd.nl/shared/genes/CYC) in the proband of the family
(Fig. 1). The c.145TNC substitution was not reported in the SNP or in
he 1000 Genome databases (http://www.ncbi.nlm.nih.gov/SNP; http://
www.1000genomes.org). As for the G41S mutation (CYCSG41S) [1],
amino acid alignments showed a perfect conservation of tyrosine 48
among cytochrome c orthologs (Fig. 1C), suggesting that the residue
exerts a fundamental role in the structure and function of the protein.
Family studies showed that individuals I-1, II-2 and II-4 were also
thrombocytopenic and carried the mutation (Fig. 1). In the affected in-
dividuals, platelet counts ranged from 73 to 135 × 109/L, suggesting
complete penetrance for thrombocytopenia. In all the patients, MPV
was within normal limits, and examination of peripheral blood smears
showed that platelets had normal size and morphology. The proband,
as well as the other three affected relatives, had no hematological or
extra-hematological defects associated with thrombocytopenia.
3.2. CYC1Y53H partially complements growth defect of yeast Δcyc1 strain
As an initial attempt to understand whether the Y48H mutation of
the human CYCS gene has any pathogenic role, we performed comple-
mentation studies in a S. cerevisiae strain carrying a deletion of CYC1,
the yeast ortholog of human CYCS. The Δcyc1 mutant displays an
OXPHOS (Oxidative Phosphorilation) negative phenotype characterized
by failure to grow inmedia containing obligatory aerobic compounds as
the only carbon sources [15]. The Δcyc1 strain was transformed with
either wild-type CYC1, or mutant alleles (sCYC1Y53H and CYC1G46S corre-
sponding equivalent to the human CYCSY48H and CYCS G41S, respective-
ly), and as well as with the empty vector, and the oxidative growth
was evaluated by spot assay analysis.
When the growth on non-fermentable carbon sources was evaluat-
ed at 28 °C, the OXPHOS negative phenotype of Δcyc1 could be rescued
by expressing both mutant alleles. However, under temperature-
induced stress conditions, i.e. at 37 °C [16,17], the oxidative growth of
both mutants strains was signiﬁcantly reduced when compared with
that of the strain expressing the wild-type allele (Fig. 2), indicating
that both mutations are not neutral change in yeast.
3.3. Defective respiratory activity in both yeast and mammalian cells ex-
pressing Y48H
The primary function of cytochrome c is to shuttle electron between
complex III and IV of themitochondrial respiratory chain. Since tyrosine
48 is located in close proximity to the heme redox center, amino acid
substitutions at this residue could interferewith themitochondrial elec-
tron ﬂow. When the respiratory activity was measured in yeast strains
expressing the CYC1Y53Hand CYC1G46Salleles incubated at 37 °C, we ob-
served a reduction in oxygen consumption of about 40% as compared
to that observed in cells expressing the wild-type gene (Fig. 3A). More-
over, in order to assess the structural integrity of the mitochondrial re-
spiratory chain complexes, the absorption spectrum of cytochromes
was measured. Both the Y53H and G46S mutations were associated
with speciﬁc reduction of about 30% in the cytochrome c contentwhere-
as that of cytochrome b did not change (Fig. 3B,C). These results corrob-
orated, at least in yeast, the pathogenetic role of the human Y48H
mutation.
In order to conﬁrm the respiratory defect in mammalian cells, we
reproduced the Y48H (CycsY48H) and G41S (CycsG41S) mutations in the
murine cDNA for their expression in immortalized mouse lung ﬁbro-
blasts,where both somatic and testis cytochrome c isoformswere delet-
ed (Cycs−/−/Cyct−/− MLF) [12]. Cytochrome c expression level was
2% glucose 2% ethanol 
28°C
37°C
wt 
pFL38
Y53H
G46S
wt 
pFL38
Y53H
G46S
Cell number
Fig. 2. Complementation studies of the CYCSmutations in yeast: oxidative growth phenotype. The BY4741 Δcyc1 strain was transformed with the pFL38 plasmid carrying the wild-type
CYC1, the mutant alleles or the empty vector. Equal amounts of serial dilutions (105, 104, 103, 102, and 101 cells) of cells from exponentially grown cultures were spotted onto YNB plates
supplemented with either 2% glucose or 2% ethanol. The growth was scored after 3 days of incubation at 28 °C or 37 °C.
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relatively stable (Fig. 4A). Since their expression levels were higher in
the cells transduced with packaging supernatants collected at 48 h
than at 24 h from virus generation, we used the former cells for the ex-
periments in this paper. First of all, we measured oxygen consumption
in Cycs−/−/Cyct−/−MLFs transducedwith theCycsY48H and CycsG41Smu-
tants. Consistent with data from yeast, intact cell coupled with endoge-
nous respiration decreased at approximately 30% with the CycsY48H
mutant (Fig. 4B). The decrement was even more evident with G41S.
The effect was less signiﬁcant in thewild-typeMEFs, given the presence
of the normal cytochrome c alleles.
3.4. The Y48H mutant has increased proapoptotic activity
In addition to its role in the mitochondrial electron transport chain,
cytochrome c is active in the intrinsic apoptotic pathway. Indeed, the
ﬁrst G41S mutation identiﬁed in cytochrome c was shown to increase
the apoptotic activity [2]. Therefore, we determined whether both mu-
tants inﬂuenced the apoptotic response to staurosporine (STS), an in-
trinsic stimulus that requires the mitochondrial apoptotic pathway to
induce cell death [18]. In Cycs−/−/Cyct−/−MLFs, CycsY48H and CycsG41S
enhanced both basal and STS-induced apoptosis, compared to the
wild-type cDNA (Fig. 5A). This effectwas also visible (although to a less-
er extent) when the mutant constructs were expressed in wild-type
MEFs (Fig. 5B).
4. Discussion
Cytochrome c is a relatively well-characterized protein involved
inmultiple essential cellular pathways such as electron transport formi-
tochondrial ATP production and intrinsic apoptosis. Although its func-
tion has been largely studied in different models, no natural occurring
mutations have been identiﬁed with the only exception of the G41Ssubstitution, whichwas found in patients belonging to a large family af-
fected with a mild form of autosomal dominant thrombocytopenia [2].
During our routine mutational screening of CYCS in patients with famil-
ial thrombocytopenia, we detected a novel variant (Y48H) that segre-
gates in a small Italian family with four affected individuals. They all
presented with a very mild thrombocytopenia with platelet size in the
normal range and without any additional features associated, a pheno-
type comparable to that of patients carrying the G41S substitution [2].
Consistent with data previously published [2], we found an in-
creased apoptotic activity when mouse cells were transfected with the
CycsY48H and CycsG41S mutants without or after an apoptotic stimulus.
Megakaryocytes produce platelets by the extension of long and
branching cytoplasmic processes, designated proplatelets, which are
protruded into the lumen of marrow sinusoids to be released into the
bloodstream. Proplatelets subsequentlymature to platelets in the circu-
lation. The apoptotic pathway regulates the timingof this process, as it is
involved in triggering proplatelet extension when mature megakaryo-
cytes approach marrow sinusoids [19]. Thus, it was hypothesized that
the proapoptotic G41S mutant induces a premature proplatelet release
within the bone marrow, rather than in the bloodstream, resulting
in ineffective platelet production. Consistently, signs of premature
proplatelet formation were observed in megakaryocytes from two pa-
tients with the G41S mutation [2]. Since Y48H showed a proapoptotic
effect similar to that of G41S, it is reasonable to hypothesize that it in-
duces thrombocytopenia through a similar mechanism. Unfortunately,
samples fromour patientswere not available to conﬁrm this hypothesis.
Tyrosine 48 is spatially close to glycine 41 and packs against the loop
whose structure is deﬁned by the presence of the glycine. Therefore, it is
possible that their similar phenotypic consequences come from a simi-
lar effect on the protein folding. For both mutations, however, the mo-
lecular mechanisms leading to alteration of respiration and apoptosis
remain obscure. As reported [4], G41S alters the heme electronic struc-
ture of cytochrome c and increases electron self exchange rate. In order
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pothesized that an increased electron transfer would accelerate genera-
tion of the oxidized form of cytochrome c, promoting apoptosis.
However, the partial defect in respiration we found in both yeast and
murine cells would argue against this hypothesis. Other hypotheses, in-
cluding a mobilization of the mutant proteins from mitochondria into
the cytosol, still need to be explored. These future studies should leadA
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(CycsY48H and CycsG41S) forms of the Cycs cDNA in Cycs−/−/Cyct−/−mouse lung ﬁbroblasts (ML
eration, as detected by SDS-PAGE and immunoblotted using antibodies against cytochrome c
mouse embryonic ﬁbroblasts (MEF) transduced with the wild-type or the mutant forms of theto a better understanding of the molecular mechanisms leading to
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5. Conclusions
In conclusion, we identiﬁed the second naturally occurring mu-
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274 D. De Rocco et al. / Biochimica et Biophysica Acta 1842 (2014) 269–274thrombocytopenia. Both mutations are associated with a defective apo-
ptosis and cellular bioenergetics. Further investigations are needed
to understand how these defects compromise megakaryopoiesis and
platelet production.
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